Outcomes and complications related to the management of Bosniak cystic renal lesions
- PMID: 25905961
- DOI: 10.2214/AJR.14.13149
Outcomes and complications related to the management of Bosniak cystic renal lesions
Abstract
Objective: The objective of our study was to evaluate outcomes and complications related to the management of Bosniak category IIF, III, and IV renal cysts.
Materials and methods: For this multiinstitutional retrospective study, a Web-based Research Electronic Data Capture (REDCap) data registry was used to record data of 286 adult patients with 312 prospectively classified Bosniak IIF, III, and IV renal cysts diagnosed between January 2000 and October 2011. Included patients were managed by surgery (n = 86), percutaneous ablation (n = 19), or imaging surveillance of 1 year or more (n = 181). The median number of years of clinical surveillance was 2.4 years (range, 0-11.7 years), 2.6 years (range, 0.4-11.4 years), and 3.2 years (range, 1.1-11.6 years) for patients managed by surgery, ablation, and imaging surveillance, respectively. Pathologic and survival outcomes and complications related to management were evaluated.
Results: The malignancy rate at surgical pathology was 38% (3/8) for Bosniak IIF, 40% (29/72) for Bosniak III, and 90% (18/20) for Bosniak IV renal cysts. There were no metastases or deaths (0/144) directly related to Bosniak IIF renal cysts. There were no deaths (0/113) directly related to Bosniak III renal cysts, although one patient (1/113) developed local progression and lung metastases after thermal ablation. One patient with a Bosniak IV renal cyst (1/29) presented with and died of metastatic disease. Moderate to severe complications occurred in 19% (16/86), 5% (1/19), and 0% (0/181) of patients managed by surgery, ablation, and imaging surveillance, respectively (p < 0.0001). Severe complications occurred in 7% (6/86) of surgical patients and included multiorgan failure (n = 2), acute myocardial infarction (n = 1), acute ischemic stroke (n = 1), conversion to hemodialysis-dependent chronic kidney disease (n = 1), and postoperative severe hemorrhage (n = 1).
Conclusion: There were no deaths from Bosniak IIF or III renal cysts regardless of management approach. Moderate to severe complications are frequent in patients managed by surgery.
Keywords: Bosniak; cystic renal tumors; renal cysts.
Comment in
-
Re: Outcomes and Complications Related to the Management of Bosniak Cystic Renal Lesions.J Urol. 2015 Oct;194(4):951-2. doi: 10.1016/j.juro.2015.07.007. Epub 2015 Jul 9. J Urol. 2015. PMID: 26382767 No abstract available.
Similar articles
-
Bosniak category IIF and III cystic renal lesions: outcomes and associations.Radiology. 2012 Jan;262(1):152-60. doi: 10.1148/radiol.11110888. Epub 2011 Nov 21. Radiology. 2012. PMID: 22106359
-
Bosniak category IIF designation and surgery for complex renal cysts.J Urol. 2009 Sep;182(3):1091-5. doi: 10.1016/j.juro.2009.05.046. Epub 2009 Jul 18. J Urol. 2009. PMID: 19616809
-
Management, pathology and outcomes of Bosniak category IIF and III cystic renal lesions.World J Urol. 2015 Mar;33(3):295-300. doi: 10.1007/s00345-014-1301-x. Epub 2014 Apr 18. World J Urol. 2015. PMID: 24744224
-
[Management of cystic renal masses: Review of the literature].Prog Urol. 2015 Oct;25(12):675-82. doi: 10.1016/j.purol.2015.05.013. Epub 2015 Jun 29. Prog Urol. 2015. PMID: 26138648 Review. French.
-
The diagnosis and management of complex renal cysts.Curr Opin Urol. 2010 Sep;20(5):349-54. doi: 10.1097/MOU.0b013e32833c7b04. Curr Opin Urol. 2010. PMID: 20592611 Review.
Cited by
-
2023 UPDATE - Canadian Urological Association guideline: Management of cystic renal lesions Prior to original publication (March 2017), this guideline underwent review by the CUA Guidelines Committee, CUA members at large, and the CUA Executive Board. The 2023 updates were app roved by the CUA Guidelines Committee and CUA Executive Board.Can Urol Assoc J. 2023 Jun;17(6):162-174. doi: 10.5489/cuaj.8389. Can Urol Assoc J. 2023. PMID: 37310905 Free PMC article. No abstract available.
-
Risk of malignancy in T1-hyperintense Bosniak version 2019 class II and IIF cystic renal masses.Abdom Radiol (NY). 2023 Aug;48(8):2636-2648. doi: 10.1007/s00261-023-03955-5. Epub 2023 May 18. Abdom Radiol (NY). 2023. PMID: 37202641
-
Deep learning and radiomic feature-based blending ensemble classifier for malignancy risk prediction in cystic renal lesions.Insights Imaging. 2023 Jan 11;14(1):6. doi: 10.1186/s13244-022-01349-7. Insights Imaging. 2023. PMID: 36629980 Free PMC article.
-
Stratification of malignant renal neoplasms from cystic renal lesions using deep learning and radiomics features based on a stacking ensemble CT machine learning algorithm.Front Oncol. 2022 Oct 25;12:1028577. doi: 10.3389/fonc.2022.1028577. eCollection 2022. Front Oncol. 2022. PMID: 36387261 Free PMC article.
-
Malignant ascites following radical nephrectomy for cystic renal cell carcinoma.BMJ Case Rep. 2021 Jul 13;14(7):e243103. doi: 10.1136/bcr-2021-243103. BMJ Case Rep. 2021. PMID: 34257120 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
